The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men

被引:133
作者
Zuo, M
Nishio, H
Lee, MJ
Maejima, K
Mimura, S
Sumino, K
机构
[1] Kobe Univ, Sch Med, Dept Publ Hlth, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Hyogo Hlth Serv Assoc, Kobe, Hyogo, Japan
关键词
MTHFR; homocysteine; uric acid;
D O I
10.1007/s100380070037
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学]; 090102 [作物遗传育种];
摘要
A common mutation, C677T, in the methylene tetrahydrofolate reductase gene (MTHFR) reduces the activity of MTHFR and increases total homocysteine levels in plasma. Increased homocysteine levels are reportedly associated with high serum uric acid levels. The relationship between the MTHFR mutation and uric acid metabolism remains unclear, however. To investigate whether the C677T MTHFR mutation is a risk factor for hyperuricemia, we performed MTHFR genotyping and clinical laboratory determinations, including serum uric acid, in 271 elderly Japanese men (age range, 40-79 years; mean, 52.6 years). The mean uric acid levels for the CIC, CIT, and TIT genotypes were 5.67, 6.00, and 6.39 mg/dl, respectively (P = 0.012). The TIT genotype was more frequent in subjects with high uric acid levels than in those with low uric acid levels (P = 0.038). These findings suggest that the C677T MTHFR mutation contributed to higher uric acid levels in subjects enrolled in this study. In conclusion, the mutation of the MTHFR gene may be a risk factor for hyperuricemia in elderly men.
引用
收藏
页码:257 / 262
页数:6
相关论文
共 31 条
[1]
AKAOKA I, 1981, J RHEUMATOL, V8, P563
[2]
PLASMA SULFHYDRYL-CONTAINING AMINO-ACIDS IN PATIENTS WITH CEREBRAL INFARCTION AND IN HYPERTENSIVE SUBJECTS [J].
ARAKI, A ;
SAKO, Y ;
FUKUSHIMA, Y ;
MATSUMOTO, M ;
ASADA, T ;
KITA, T .
ATHEROSCLEROSIS, 1989, 79 (2-3) :139-146
[3]
HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[4]
Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease [J].
Christensen, B ;
Frosst, P ;
LussierCacan, S ;
Selhub, J ;
Goyette, P ;
Rosenblatt, DS ;
Genest, J ;
Rozen, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :569-573
[5]
ELEVATED PLASMA HOMOCYST(E)INE CONCENTRATION AS A POSSIBLE INDEPENDENT RISK FACTOR FOR STROKE [J].
COULL, BM ;
MALINOW, MR ;
BEAMER, N ;
SEXTON, G ;
NORDT, F ;
DEGARMO, P .
STROKE, 1990, 21 (04) :572-576
[6]
Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[7]
GENETIC-CONTROL OF THE RENAL CLEARANCE OF URATE - A STUDY OF TWINS [J].
EMMERSON, BT ;
NAGEL, SL ;
DUFFY, DL ;
MARTIN, NG .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (03) :375-377
[8]
Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia [J].
Evers, S ;
Koch, HG ;
Grotemeyer, KH ;
Lange, B ;
Deufel, T ;
Ringelstein, EB .
ARCHIVES OF NEUROLOGY, 1997, 54 (10) :1276-1282
[9]
RELATION OF SERUM URIC-ACID TO MORTALITY AND ISCHEMIC-HEART-DISEASE - THE NHANES-I EPIDEMIOLOGIC FOLLOW-UP-STUDY [J].
FREEDMAN, DS ;
WILLIAMSON, DF ;
GUNTER, EW ;
BYERS, T .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (07) :637-644
[10]
A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113